Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599651 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)
A NA study, sponsored by University of Virginia.
- Terminated
- Registry status
- NA
- Development phase
- 380
- Enrollment target
NCT00599651: Clinical Trial NA study, sponsored by University of Virginia.
NCT00599651 is a NA study that was terminated before completion, run by University of Virginia. The registered enrollment target is 380 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00599651, a NA study, was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
Study Summary
In this protocol we will conduct a randomized controlled trial where babies with respiratory distress syndrome (RDS) who have not yet reached criteria for intubation, will be randomized to receive surfactant by LMA or to continue receiving standard therapy of nasal CPAP and supplemental oxygen. All babies will be given surfactant by endotracheal tube if they reach "failure" criteria, which is the standard criterion for surfactant administration (i.e., FiO2= 65% while receiving nasal CPAP). The objective of this RCT is to determine if surfactant can be successfully administered by LMA, thus perhaps avoiding the need for endotracheal intubation. The hypothesis is that fewer babies in the LMA group would reach failure criteria.
Interventions
- DEVICE Surfactant administered via Laryngeal Mask Airway (LMA)
- OTHER standard of care (nasal CPAP and supplemental oxygen)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2005-06 |
| Est. Completion | 2009-12 |
| Phase | NA |
Why NCT00599651 stopped before completion
NCT00599651 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Surfactant administered via Laryngeal Mask Airway (LMA) is the first listed.
NCT00599651 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00599651 about?
NCT00599651 is a clinical study titled "Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)". In this protocol we will conduct a randomized controlled trial where babies with respiratory distress syndrome (RDS) who have not yet reached criteria for intubation, will be randomized to receive surfactant by LMA or to continue receiving standard therapy of nasal CPAP and supplemental oxygen. All ...
What is the current status of trial NCT00599651?
This trial is currently terminated. It is a NA study. The enrollment target is 380 participants. The study started on 2005-06. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00599651?
The interventions under investigation include: Surfactant administered via Laryngeal Mask Airway (LMA) (DEVICE), standard of care (nasal CPAP and supplemental oxygen) (OTHER).
Who is sponsoring clinical trial NCT00599651?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00599651's enrollment target sits among peer trials
380 273rd of 2000 higher than 1,727 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia